Bioactive Polymer Dressing with Immune Modulation for Wound Closure
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current wound healing technologies, such as sutures, dressings, and growth factor therapies, are inadequate for friable or chronic wounds, leading to prolonged healing times and high healthcare costs, with existing methods like laser tissue welding facing issues of chromophore stability and tissue integration.
Innovation Solution
A bioactive wound dressing incorporating a structural material, immunomodulatory agents like histamine, and growth factors, optionally with laser stimulation, to enhance wound healing by modulating the immune response and promoting tissue regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional closure methods (sutures, staples, adhesives) are used, then wound closure is achieved, but they cause tissue trauma, inflammation, and poor integration with friable or chronic wounds
Solution Approach 1:
The patent replaces mechanical closure systems (sutures, staples, adhesives) with a biocompatible polymer dressing system that promotes natural wound healing. The dressing integrates with tissue through biological processes rather than mechanical fastening, eliminating trauma and inflammation caused by puncture wounds, pressure points, and adhesive reactions.
Solution Approach 2:
The patent employs a composite polymer dressing formulation combining biocompatible materials with varying degradation rates. The composite structure includes a structural polymer matrix integrated with biological components, allowing the dressing to provide mechanical support while simultaneously promoting tissue regeneration and integration without causing harm.
2Productivity
If growth factor therapies are used, then wound healing is promoted, but costs increase significantly and efficacy is modest
Solution Approach 1:
The patent incorporates growth factors and immunomodulatory agents directly into the biodegradable polymer dressing matrix, enabling the wound site to self-regulate healing through controlled local release. This eliminates the need for repeated expensive clinical interventions and high-dose systemic growth factor applications, achieving sustained therapeutic effects at lower overall cost.
Solution Approach 2:
The patent pre-loads the polymer dressing with growth factors and immunomodulatory agents during manufacturing, preparing the wound site in advance with controlled release capabilities. This preliminary action ensures immediate therapeutic effect upon application and maintains optimal concentrations throughout the healing process, avoiding the need for repeated expensive treatments.
3Speed
If laser tissue welding with liquid chromophore systems is used, then rapid tissue sealing is achieved, but chromophore stability is poor due to photobleaching and leaching
Solution Approach 1:
The patent integrates a stable chromophore into the solid polymer matrix structure, creating a composite material where the chromophore is physically and chemically stabilized. This prevents photobleaching and leaching while maintaining laser absorption capability, enabling rapid tissue sealing with sustained chromophore activity throughout the procedure.
Solution Approach 2:
The patent uses a thin film polymer dressing structure that allows efficient laser energy transmission and chromophore activation. The thin film format ensures uniform chromophore distribution and maintains structural integrity during laser application, enabling rapid and stable tissue welding without chromophore degradation.
4Reliability
If biodegradable dressings are used, then tissue integration is improved, but bacterial sequestration and healing inhibition may occur
Solution Approach 1:
The patent applies different functional properties to different regions of the polymer dressing. The surface layer is designed with antimicrobial properties to prevent bacterial colonization, while the bulk material maintains biodegradability and tissue integration capabilities. This local differentiation allows simultaneous achievement of tissue integration and bacterial resistance.
Solution Approach 2:
The patent modifies the chemical and physical parameters of the polymer dressing, including surface charge, hydrophobicity, and crosslinking density, to create zones with different biological interactions. These parameter changes enable the dressing to repel bacteria while maintaining favorable conditions for tissue integration and controlled degradation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Accelerates wound closure and improves tissue strength in acute and diabetic wounds, outperforming conventional dressings by enhancing immune response and tissue integration, with laser stimulation providing additional therapeutic benefits.
Implementation Method 1
at least one immunomodulatory agent associated with the dressing
Implementation Method 2
a growth factor associated with the dressing
Implementation Method 3
an exposed chromophore converts laser light to heat to rapidly seal tissue wounds or incisions
Data Source
AI summary
A wound dressing includes: a structural material formed into a dressing; at least one immunomodulatory agent associated with the dressing; and a growth factor associated with the dressing. A wound dressing kit includes: a structural material formed into a wound dressing; an immunomodulatory agent; and a growth factor composition, wherein the structural material contains the immunomodulatory agent and/or the immunomodulatory agent is in a separate composition. A method of treating a wound in a tissue includes: applying an immunomodulatory agent to the wound; applying a wound dressing to the wound; and allowing the wound to heal with the immunomodulatory agent and wound dressing. The application of a growth factor can be before, during and/or after applying the wound dressing to the wound.